Genome-wide Meta-analysis Identifies Novel Multiple Sclerosis Susceptibility Loci

Objective: To perform a 1-stage meta-analysis of genome-wide association studies (GWAS) of multiple sclerosis (MS) susceptibility and to explore functional consequences of new susceptibility loci.

Methods: We synthesized 7 MS GWAS. Each data set was imputed using HapMap phase II, and a per single nucleotide polymorphism (SNP) meta-analysis was performed across the 7 data sets. We explored RNA expression data using a quantitative trait analysis in peripheral blood mononuclear cells (PBMCs) of 228 subjects with demyelinating disease.

Results: We meta-analyzed 2,529,394 unique SNPs in 5,545 cases and 12,153 controls. We identified 3 novel susceptibility alleles: rs170934(T) at 3p24.1 (odds ratio [OR], 1.17; p = 1.6 × 10(-8)) near EOMES, rs2150702(G) in the second intron of MLANA on chromosome 9p24.1 (OR, 1.16; p = 3.3 × 10(-8)), and rs6718520(A) in an intergenic region on chromosome 2p21, with THADA as the nearest flanking gene (OR, 1.17; p = 3.4 × 10(-8)). The 3 new loci do not have a strong cis effect on RNA expression in PBMCs. Ten other susceptibility loci had a suggestive p < 1 × 10(-6) , some of these loci have evidence of association in other inflammatory diseases (ie, IL12B, TAGAP, PLEK, and ZMIZ1).

Interpretation: We have performed a meta-analysis of GWAS in MS that more than doubles the size of previous gene discovery efforts and highlights 3 novel MS susceptibility loci. These and additional loci with suggestive evidence of association are excellent candidates for further investigations to refine and validate their role in the genetic architecture of MS.

Citing Articles

GWAS highlights the neuronal contribution to multiple sclerosis susceptibility.

De Jager P, Zeng L, Khan A, Lama T, Chitnis T, Weiner H Res Sq. 2025; .

PMID: 39866869 PMC: 11760239. DOI: 10.21203/rs.3.rs-5644532/v1.

Prophylactic administration of PEPITEM in experimental autoimmune encephalomyelitis delays disease onset, inhibits leukocyte infiltration, and alleviates severity.

Alassiri M, Al Sufiani F, Aljohi M, Alanazi A, Alhazmi A, Alrfaei B Int J Clin Exp Pathol. 2025; 17(12):492-505.

PMID: 39802871 PMC: 11711485. DOI: 10.62347/LTAO2386.

GWAS highlights the neuronal contribution to multiple sclerosis susceptibility.

Zeng L, Atlas K, Lama T, Chitnis T, Weiner H, Wang G medRxiv. 2024; .

PMID: 39677438 PMC: 11643295. DOI: 10.1101/2024.12.04.24318500.

Selected Aspects of the Neuroimmunology of Cell Therapies for Neurologic Disease: Perspective.

Ransohoff R Neurol Neuroimmunol Neuroinflamm. 2024; 12(1):e200352.

PMID: 39671535 PMC: 11649171. DOI: 10.1212/NXI.0000000000200352.

The refined Pathways to Cures Research Roadmap for multiple sclerosis cures.

Bebo Jr B, Banwell B, Whitacre C, Coetzee T, Dalgas U, De Jager P Mult Scler. 2024; 30(10):1242-1251.

PMID: 39212108 PMC: 11451078. DOI: 10.1177/13524585241266483.

References

McKeown P, Merlini P, Berzuini C, Bernardinelli L, Peyvandi F, Tubaro M . Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet. 2009; 41(3):334-41. PMC: 2681011. DOI: 10.1038/ng.327. View

Aulchenko Y, Hoppenbrouwers I, Ramagopalan S, Broer L, Jafari N, Hillert J . Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis. Nat Genet. 2008; 40(12):1402-3. DOI: 10.1038/ng.251. View

Maier L, Lowe C, Cooper J, Downes K, Anderson D, Severson C . IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production. PLoS Genet. 2009; 5(1):e1000322. PMC: 2602853. DOI: 10.1371/journal.pgen.1000322. View

. Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci. Hum Mol Genet. 2009; 19(5):953-62. PMC: 2816610. DOI: 10.1093/hmg/ddp542. View

Samani N, Erdmann J, Hall A, Hengstenberg C, Mangino M, Mayer B . Genomewide association analysis of coronary artery disease. N Engl J Med. 2007; 357(5):443-53. PMC: 2719290. DOI: 10.1056/NEJMoa072366. View

McDonald W, Compston A, Edan G, Goodkin D, Hartung H, Lublin F . Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001; 50(1):121-7. DOI: 10.1002/ana.1032. View

de Beaucoudrey L, Puel A, Filipe-Santos O, Cobat A, Ghandil P, Chrabieh M . Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med. 2008; 205(7):1543-50. PMC: 2442631. DOI: 10.1084/jem.20080321. View

Smyth D, Plagnol V, Walker N, Cooper J, Downes K, Yang J . Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med. 2008; 359(26):2767-77. PMC: 2840835. DOI: 10.1056/NEJMoa0807917. View

Jakkula E, Leppa V, Sulonen A, Varilo T, Kallio S, Kemppinen A . Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. Am J Hum Genet. 2010; 86(2):285-91. PMC: 2820168. DOI: 10.1016/j.ajhg.2010.01.017. View

10.

de Bakker P, Ferreira M, Jia X, Neale B, Raychaudhuri S, Voight B . Practical aspects of imputation-driven meta-analysis of genome-wide association studies. Hum Mol Genet. 2008; 17(R2):R122-8. PMC: 2782358. DOI: 10.1093/hmg/ddn288. View

11.

Price A, Patterson N, Plenge R, Weinblatt M, Shadick N, Reich D . Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006; 38(8):904-9. DOI: 10.1038/ng1847. View

12.

Gauthier S, Mandel M, Guttmann C, Glanz B, Khoury S, Betensky R . Predicting short-term disability in multiple sclerosis. Neurology. 2007; 68(24):2059-65. DOI: 10.1212/01.wnl.0000264890.97479.b1. View

13.

Nicolae D, Gamazon E, Zhang W, Duan S, Dolan M, Cox N . Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet. 2010; 6(4):e1000888. PMC: 2848547. DOI: 10.1371/journal.pgen.1000888. View

14.

Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

15.

Brynedal B, Duvefelt K, Jonasdottir G, Roos I, Akesson E, Palmgren J . HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis. PLoS One. 2007; 2(7):e664. PMC: 1919434. DOI: 10.1371/journal.pone.0000664. View

16.

Nair R, Callis Duffin K, Helms C, Ding J, Stuart P, Goldgar D . Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet. 2009; 41(2):199-204. PMC: 2745122. DOI: 10.1038/ng.311. View

17.

Brereton C, Sutton C, Lalor S, Lavelle E, Mills K . Inhibition of ERK MAPK suppresses IL-23- and IL-1-driven IL-17 production and attenuates autoimmune disease. J Immunol. 2009; 183(3):1715-23. DOI: 10.4049/jimmunol.0803851. View

18.

Hauser S, Oksenberg J . The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron. 2006; 52(1):61-76. DOI: 10.1016/j.neuron.2006.09.011. View

19.

Stahl E, Raychaudhuri S, Remmers E, Xie G, Eyre S, Thomson B . Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet. 2010; 42(6):508-14. PMC: 4243840. DOI: 10.1038/ng.582. View

20.

. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet. 2009; 41(7):824-8. DOI: 10.1038/ng.396. View